Search Login Register

Mydriasis Summary

Description: Dilation of pupils to greater than 6 mm combined with failure of the pupils to constrict when stimulated with light. This condition may occur due to injury of the pupillary fibers in the oculomotor nerve, in acute angle-closure glaucoma, and in ADIE SYNDROME.

Key Drugs and Agents for Mydriasis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Phenylephrine (Neo-Synephrine) : 9 outcomes 16 studies in 119 results : FDA 17 Generic
  2. Ophthalmic Solutions (Eye Drops) : 6 outcomes 11 studies in 43 results : IBA
  3. Tropicamide : 5 outcomes 10 studies in 84 results : FDA 15 Generic
  4. Epinephrine (Adrenaline) : 5 outcomes 2 studies in 31 results : FDA 93 Generic
  5. Flurbiprofen (Froben) : 4 outcomes 2 studies in 13 results : FDA 11 Generic
  6. dapiprazole (Rev-Eyes) : 3 outcomes 4 studies in 14 results : FDA 1
  7. Diclofenac (SR 38) : 3 outcomes in 11 results : FDA 39 Generic
  8. Cyclopentolate (Cyclogyl) : 2 outcomes 4 studies in 28 results : FDA 3 Generic
  9. Atropine (Hyoscyamine) : 2 outcomes 3 studies in 50 results : FDA 46 Generic
  10. nepafenac (Nevanac) : 2 outcomes 2 studies in 4 results : FDA 1
Show All >>

Diseases Related to Mydriasis

  1. Cataract (Cataracts)
  2. Uveitis
  3. Inflammation
  4. Miosis
  5. Pain (Aches)
Show All >>

Key Therapies for Mydriasis

Efficacy Chart >>
  1. Phacoemulsification : 1 outcome 1 study in 22 results
  2. Topical Administration : 1 outcome 1 study in 5 results
  3. Intraocular Lenses (Intraocular Lens) : 1 outcome in 16 results
  4. Cataract Extraction : 1 outcome in 15 results
  5. Injections : 1 outcome in 6 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.